Routine Cardiac Screening in Sarcoidosis Patients

CompletedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

April 5, 2019

Primary Completion Date

November 1, 2024

Study Completion Date

November 1, 2024

Conditions
SarcoidosisCardiac SarcoidosisBoeck's DiseaseBesnier-Boeck Disease
Interventions
DIAGNOSTIC_TEST

Enhanced Screening Protocol for Cardiac Sarcoidosis.

To utilize enhanced screening tests for cardiac sarcoidosis in an undiagnosed and potentially under-diagnosed patient population to determine the rate of missed cardiac sarcoidosis diagnosis. Following testing by the standard screening tests, this intervention includes a subsequent echocardiogram and a wearable ECG, also known as a Holter Monitor or ambulatory ECG.

DIAGNOSTIC_TEST

Routine Screening for Suspected Cardiac Sarcoidosis

To utilize standard of care screening tests for cardiac sarcoidosis. This includes symptom check and a standard ECG.

Trial Locations (12)

12208

Albany Medical Center, Albany

19104

Penn Medicine, Philadelphia

29425

Medical University of South Carolina, Charleston

44195

Cleveland Clinic, Cleveland

45219

University of Cincinnati Medical Center, Cincinnati

52242

University of Iowa Hospital, Iowa City

60611

Northwestern University Medicine, Chicago

60612

University of Illinois Medical Center At Chicago, Chicago

80206

National Jewish Health, Denver

98195

University of Washington Medical Center, Seattle

Unknown

St. Antonius, Amsterdam

Royal Papworth Hospital, Cambridge

All Listed Sponsors
lead

Foundation for Sarcoidosis Research

OTHER

NCT03902223 - Routine Cardiac Screening in Sarcoidosis Patients | Biotech Hunter | Biotech Hunter